4 Results for "

Deruxtecan 2-hydroxypropanamide

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "Deruxtecan 2-hydroxypropanamide" in MCE Product Catalog:

Cat. No.: HY-153891
CAS No.: 2577204-16-9
Purity:  99.69%
Target:  

Drug Intermediate

Research Areas:  

Cancer

Deruxtecan 2-hydroxypropanamide is a highly stable Deruxtecan (HY-13631E) analog that specifically binds to receptors highly expressed in tumor cells .
loading...
    loading...
Cat. No.: HY-153892
CAS No.: 2750623-07-3
Purity:  99.79%
Research Areas:  

Cancer

Gly-Mal-GGFG-Deruxtecan 2-hydroxypropanamide is the drug-linker conjugate for ADC, containing ADC linker Gly-Mal-GGFG and ADC cytotoxin Deruxtecan 2-hydroxypropanamide .
loading...
    loading...
Cat. No.: HY-164702
Synonyms: Izalontamab Brengitecan
Research Areas:  

Cancer

BL-B01D1 (Izalontamab Brengitecan) is a bispecific antibody-drug conjugate (ADC) targeting EGFR and HER3, formed by conjugating the EGFR/HER3 bispecific antibody Izalontamab (HY-P99676) to a novel TOP-I inhibitor payload Deruxtecan 2-hydroxypropanamide (HY-153891) via a cleavable linker (Mc-Gly-Gly-Phe-Gly). BL-B01D1 binds to EGFR and HER3 on the surface of tumor cells, mediates endocytosis and releases the payload, inhibits topoisomerase I, blocks DNA replication and RNA synthesis, and disrupts DNA structure. BL-B01D1 induces cell cycle S-phase arrest, apoptosis, antibody-dependent cell-mediated cytotoxicity, and tumor cell death. BL-B01D1 can be used for cancer research .
loading...
    loading...
Cat. No.: HY-153891S
Deruxtecan 2-hydroxypropanamide-d5 is a deuterated isotope of Deruxtecan 2-hydroxypropanamide (HY-153891) .
loading...
    loading...